COVID-19 infection and nanomedicine applications for development of vaccines and therapeutics: An overview and future perspectives based on polymersomes

Mohammad A I Al-Hatamleh,Ma'mon M Hatmal,Walhan Alshaer,Engku Nur Syafirah E A Rahman,Manali Haniti Mohd-Zahid,Dina M Alhaj-Qasem,Chan Yean Yean,Iskandar Z Alias,Juhana Jaafar,Khalid Ferji,Jean-Luc Six,Vuk Uskoković,Hiroshi Yabu,Rohimah Mohamud
DOI: https://doi.org/10.1016/j.ejphar.2021.173930
2021-04-05
Abstract:The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), which emerged in December 2019 and caused the coronavirus disease 2019 (COVID-19) pandemic, took the world by surprise with an unprecedented public health emergency. Since this pandemic began, extraordinary efforts have been made by scientists to understand the pathogenesis of COVID-19, and to fight the infection by providing various preventive, diagnostic and treatment opportunities based on either novel hypotheses or past experiences. Despite all the achievements, COVID-19 continues to be an accelerating health threat with no specifically approved vaccine or therapy. This review highlights the recent advances in COVID-19 infection, with a particular emphasis on nanomedicine applications that can help in the development of effective vaccines or therapeutics against COVID-19. A novel future perspective has been proposed in this review based on utilizing polymersome nano-objects for effectively suppressing the cytokine storm, which may reduce the severity of COVID-19 infection.
What problem does this paper attempt to address?